Impact of metastatic pattern and histologic subtype on PD-(L)1 inhibitor efficacy in HER2-negative advanced gastric and gastroesophageal cancer: a meta-analysis

By afschroeder • July 15, 2026

Tai D, Kim KI, Shah P, Park D, Kim L, Li J, Jung C, Guzman S, Brar G, Wu S, Castillo D. Impact of metastatic pattern and histologic subtype on PD-(L)1 inhibitor efficacy in HER2-negative advanced gastric and gastroesophageal cancer: a meta-analysis. Front Oncol. 2026 Jun 29;16:1857990. doi: 10.3389/fonc.2026.1857990. PMID: 42444824; PMCID: PMC13357174.

Tags: Fellow, gastric cancer, gastroesophageal junction, Harbor UCLA, Hematology/Oncology, immunotherapy, Lauren classification, metastatic site, PD-1 blockade, Publications

Investigating the Kidney-Gut-Brain Axis in CKD: Uremic Toxins and Brain Microhemorrhages

Zhao Y, Lee SM, Li W, Floriolli D, Chang P, Narasaki Y, You AS, Kalantar-Zadeh K, Rhee CM, Liu H, Tran T, Paganini-Hill A, Fisher[...]

Comparative Effectiveness of Lipid-Lowering Therapies in Increasing High-Density Lipoprotein Cholesterol Levels in Patients with Chronic Kidney Disease

Naim MAAZ, Thomas F, Streja E, Davis RL, Kalantar-Zadeh K, Sumida K, Kovesdy CP. Comparative Effectiveness of Lipid-Lowering Therapies in Increasing High-Density Lipoprotein Cholesterol Levels[...]

Dynamic Assessment of Exercise Gas Exchange Efficiency by Breath-by-Breath Volumetric Capnography in Mild-Moderate COPD

James MD, McCleary J, Back GD, Alosta KA, Smyth RM, Vincent SG, Wang CY, Domnik NJ, Borghi-Silva A, Stringer W, Porszasz J, O'Donnell DE, Neder[...]